Cross-species RNA-seq study comparing transcriptomes of enriched osteocyte populations in the tibia and skull by Wang, N. et al.
This is a repository copy of Cross-species RNA-seq study comparing transcriptomes of 
enriched osteocyte populations in the tibia and skull.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/166308/
Version: Published Version
Article:
Wang, N., Niger, C., Li, N. et al. (2 more authors) (2020) Cross-species RNA-seq study 
comparing transcriptomes of enriched osteocyte populations in the tibia and skull. 
Frontiers in Endocrinology, 11. 581002. ISSN 1664-2392 
https://doi.org/10.3389/fendo.2020.581002
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence 
allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the 
authors for the original work. More information and the full terms of the licence here: 
https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
ORIGINAL RESEARCH
published: 24 September 2020
doi: 10.3389/fendo.2020.581002
Frontiers in Endocrinology | www.frontiersin.org 1 September 2020 | Volume 11 | Article 581002
Edited by:
Katherine A. Staines,
University of Brighton,
United Kingdom
Reviewed by:
Katharina Jähn-Rickert,
University Medical Center
Hamburg-Eppendorf, Germany
Beata Lecka-Czernik,
University of Toledo, United States
*Correspondence:
Tim M. Skerry
t.skerry@sheffield.ac.uk
†These authors have contributed
equally to this work
Specialty section:
This article was submitted to
Bone Research,
a section of the journal
Frontiers in Endocrinology
Received: 07 July 2020
Accepted: 21 August 2020
Published: 24 September 2020
Citation:
Wang N, Niger C, Li N, Richards GO
and Skerry TM (2020) Cross-Species
RNA-Seq Study Comparing
Transcriptomes of Enriched Osteocyte
Populations in the Tibia and Skull.
Front. Endocrinol. 11:581002.
doi: 10.3389/fendo.2020.581002
Cross-Species RNA-Seq Study
Comparing Transcriptomes of
Enriched Osteocyte Populations in
the Tibia and Skull
Ning Wang 1†, Corinne Niger 1†, Nan Li 2, Gareth O. Richards 1 and Tim M. Skerry 1*
1Department of Oncology and Metabolism, Mellanby Centre for Bone Research, University of Sheffield, Sheffield,
United Kingdom, 2Department of Neuroscience, Sheffield Institute for Translational Neuroscience (SITraN), University of
Sheffield, Sheffield, United Kingdom
Local site-specific differences between bones in different regions of the skeleton
account for their different properties and functions. To identify mechanisms behind these
differences, we have performed a cross-species study comparing RNA transcriptomes
of cranial and tibial osteocytes, from bones with very different primary functions
and physiological responses, collected from the same individual mouse, rat, and
rhesus macaque. Bioinformatic analysis was performed to identify 32 genes changed
in the same direction between sites and shared across all three species. Several
well-established key genes in bone growth and remodeling were upregulated in the tibias
of all three species (BMP7, DKK1, FGF1, FRZB, SOST). Many of them associate or
crosstalk with the Wnt signaling pathway. These results suggest Wnt signaling-related
candidates for different control of regulatory mechanisms in bone homeostasis in the
skull and tibia and indicate a different balance between genetically determined structure
and feedbackmechanisms to strains induced bymechanical loading at the different sites.
Keywords: osteocytes, RNA-Seq, Wnt signaling, cross-species, bone remodeling
INTRODUCTION
Patterning during embryogenesis accounts for the development of all the specialized tissues and
organs in multicellular organisms (1). Skeletal patterning accounts for the shape and structure
of different bones and their behavior during life. However, mechanical forces provide additional
potent influences on most parts of the skeleton, both before (2, 3) and after birth (4). This process
of skeletal adaptation tunes bone strength to prevailing functional demands, adding material above
a genetically determined baseline structure that forms and is retained even in the absence of
loading stimuli.
The physical demands on bones, and therefore their optimal structures vary with their
site in the skeleton. These form/function relationships vary widely throughout the skeleton
(5), but we can consider examples at the opposite ends of the spectrum. Long bones
need to be rigid levers for efficient locomotion, while the skull provides protection for
the vulnerable brain. Structure of long bones in the limbs is regulated by the loads
they experience during physiological activity (6), while the skull must retain mass and
strength to resist damaging events despite the absence of any significant or regular loading.
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We have shown that in a human subject, the peak strains
experienced in the skull even under extreme physiological
circumstances do not reach 1/10th of the magnitude or rate
those in the tibia of the same person (7). Such low strains
would be perceived as disuse in a long bone, yet skull bone
integrity is retained even in wasting conditions that deplete
material in other parts of the skeleton. As all the bones in the
skeleton experience the same circulating milieu of hormones
and nutrients, it seems therefore that site-specific differences
in regulation of bone formation and resorption must exist to
account for regional differences. It might be considered that
any differences between the skull and long bones are related
to the embryological origins of the bone at the two sites,
rather than their functional differences. This is unlikely because
the clavicle is an example of a bone that is formed partly
through endochondral ossification (like the long bones) and
partly through intramembranous ossification (like the skull).
The clavicles are bones which are known to adapt to function
and lose bone mass through disuse, like long bones and unlike
the skull (8), suggesting that intramembranous ossification is
not invariably associated with a lack of sensitivity to disuse.
Furthermore, the lateral end of the clavicle, which is the part
formed by intramembranous ossification is affected by a bone
wasting condition that has no effect on bone mass in the skull (9).
In order to identify the biological basis for site specific
regulation of bone mass and structure we have used RNA
sequencing to compare the transcriptomes of samples of skull
and tibial bones from three species: mouse, rat, and rhesus
macaque. Others have tried to address this question in the past,
using bone samples (that included bone marrow) from young
rats (10, 11) and mice (12), identifying several 100 genes that
appeared regulated differently between sites. The cross-species
design allowed us to focus our results on what we believe are
broad biological mechanisms, and resulted in only a relatively
small number of differences between sites that were shared
across species and are therefore likely to reflect mechanisms in
humans. The method we designed was to focus attention on
enriched osteocytes populations, because osteocytes are widely
accepted to be the mechanosensors in bone (13), responding
rapidly to mechanical loading (14), and so influencing bone
formation and resorption. More importantly, evidence has
suggested that osteocytes, constituting more than 90% of bone
cells, use the Wnt signaling pathway involving sclerostin and
Dkk1, and crosstalk with the prostaglandin pathway in response
to mechanical loading (15–17). Our current study has provided
further evidence to support this notion but from a site-specific
differences perspective.
MATERIALS AND METHODS
Experimental Animals
Four-month old female C57BL/6 mice (Charles River, Harlow,
UK), 6-month old female Wistar rats (Charles River, Harlow,
UK), and 4–6 year old female rhesus macaques (Macaca mulatta)
were used in this study. These ages represent bones which have
undergone their periods of maximum growth rate for each
species, and so transcriptome analysis should not be confounded
by rapid growth of the skeleton (18). Long bones (tibias) and
calvariae were dissected free of soft tissue after animals were
euthanased. All procedures complied with the United Kingdom
Animals (Scientific Procedures) Act 1986 (PPL 40/3499).
Bone Tissue Preparation
To obtain highly enriched populations of osteocytes, tibias of
mouse and rat were cut to expose the metaphysis and centrifuged
briefly to remove bone marrow (1,500 g, 30 s). Calvarial samples
were obtained from the rodents with scissors, removing the
sutures and avoiding any marrow spaces (diploe). Samples were
obtained from the Macaque bones with a hacksaw irrigated with
normal saline. All samples were dissected free of periosteum
and accessible surfaces were scraped with a scalpel. They were
then immersed briefly in a 1 mg/ml solution of collagenase
(Sigma Aldrich) for 3–5min at 37◦C to remove any adherent
surface cells. Samples were then washed in saline before being
snap frozen by complete submersion in liquid nitrogen and
then stored at −80◦C. Bone samples were pulverized using
a Mikro-Dismembrator-S (Braun Biotech International GmbH
Melsungen, Germany), in which the bone is shaken in a robust
PTFE mill chamber with an 8mm tungsten carbide ball (both
cooled in liquid nitrogen before use, and again after adding the
bone pieces, before agitation). The mill with tissue sample was
placed within the Mikro-Dismembrator-S and set to shake at
2,500 rpm for 45 s. The weight of the fine bone powder was
recorded and it was stored for RNA extraction.
RNA Extraction From Bone
One milliliter of Trizol Reagent (Ambion) was added per
125mg of pulverized tissue (typical tissue amounts 350–500mg);
samples were incubated in Trizol reagent for 10min at room
temperature. Samples were centrifuged at 500 g for 5min at 4◦C,
the supernatant was removed carefully to ensure no debris was
transferred. 0.3ml of chloroform was added to each 1ml of
Trizol reagent, the sample was thoroughly mixed and allowed
to incubate at room temperature for 5min. The samples were
centrifuged at 12,000 g for 20min at 4◦C. The colorless upper
phase was collected and transferred to a separate tube, to which
an equal volume of 70% ethanol was added and incubated at
room temperature for 10 min.
The samples were then applied to spin cartridges from TRIzol
Plus RNA purification kit (Ambion) following the manufactures
instructions using the optional On-Column PureLink DNase
(Invitrogen) treatment step. Samples were quantified using
spectrophotometry (NanoDrop Thermo) and quality measured
using a Bioanalyzer (Agilent). Only RNA with a RNA integrity
number (RIN) above 8 was stored in −80◦C and used for RNA-
Seq. Samples used for analysis were one long bone and skull
pair pooled from two rats, two long bone, and skull pairs each
pooled from 3 mice, and 3 long bone, and skull pairs each from
individual macaques.
Library Preparation and Sequencing
cDNA library preparation and sequencing were performed by
Eurofins Genomic (Ebersberg, Germany). From the total RNA
sample, poly(A)+ RNA was enriched and randomized primer
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was used for first strand cDNA synthesis. Sequencing was
performed in the 1 × 125 bp run mode, 6 samples/channel
on Illumina HiSeq 2500 and generated 30 million reads/sample
on average. The %Q30 of each samples were all above
86% and detailed quality control metrics were shown in
Supplementary Table 1. Complete RNA sequencing data was
submitted to the Gene Expression Omnibus under accession
record GSE151971.
RNA-Seq Data Processing and Functional
Gene Annotation
RNA-seq data analysis pre-processing and functional gene
annotation was performed by Bioinformatics Consultants
(Stockholm, Sweden). Reference genome sequences and gene
annotations for Rattus norvegicus (rn6) and Mus musculus
(mm10) were downloaded from UCSC. For Macaca mulatta
we used the MacaM genome assembly (https://www.unmc.
edu/rhesusgenechip/index.htm) and its corresponding gene
annotations (19). Exons of genes with multiple isoforms were
merged according to their genomic coordinates using a custom
Perl script. HISAT2 (v. 2.0.5) with default settings was used
for mapping the sequencing reads to each respective genome
(20). Sequencing reads were then counted on gene models
with the HTSeq-count program (the –s flag set to “no”) (21).
Differential gene expression was analyzed with the R package
edgeR v. 3.16.5 for each species/individual separately (22). Any
gene with zero read counts in at least one sample was removed,
in order to lower the chance of quantifying expression from
genes with incomplete annotation in one or more genomes. The
trimmed mean of M-values (TMM) normalization was applied
to raw read counts prior to testing for differential expression
(23). Finally, differential expression was defined as genes with a
false discovery rate < 20% and an absolute fold change higher
than 1.1 (24, 25). In the heat-map plots, raw read counts were
TMM normalized, and a variance stabilizing transformation
was applied (26). Heat-maps were rendered with the heatmap.2
function in the gplots R package. Three-way ortholog pairs across
the three genomes were determined through their gene symbols
with the same direction of gene expression. For functional
gene annotation analysis, gene Ontology enrichment analysis
was conducted on all identified three-way ortholog pairs with
GOrilla (GeneOntology enRIchment anaLysis and visuaLizAtion
tool) (27), PANTHER (protein annotation through evolutionary
relationship) classification system (28), andDAVID (Database for
Annotation, Visualization and Integrated Discovery) (29). Gene
Set Enrichment Analysis (GSEA) (30) was also conducted with
GSEA v.2.2.3, ran with MSigDB v. 5.2 (gene set definitions) (31).
RESULTS
Pipeline Design
Orthologs across the three genomes were initially determined
using OrthoDB (32). A principal component analysis (PCA)
was conducted on the 12 samples using normalized expression
of 1:1:1 orthologs. The result of this analysis showed that
samples generally clustered according to species and not by
sample site (Figure 1A), which indicates that the phylogenetic
divergence is stronger than site differences. Similar results
can also be seen through pairwise comparisons in a heat-
map where samples from the same species but different sites
have more similar expression profile than samples of the same
sites from a different species (Figure 1B). This could be a
consequence of analysis based on the limited 14,308 three-
way orthologs that can be mapped 1:1:1 between Rat-Mouse-
Macaque, due to incomplete genome annotations at the time
OrthoDB was compiled. Therefore, to achieve enough power
to detect transcriptome differences between different sites of
skeleton across species, the differential expression (DE) analysis
was carried out for each species/individual separately and
orthologs were then determined using a simpler approach where
the ortholog relationship is found through their gene symbols
and same direction of gene expression. To this end, we propose
a pipeline to determine transcriptome differences across species,
which comprises of sequencing reads mapped using HISAT2,
DE analysis with the R package edgeR v. 3.16.5, and gene
symbols based three-way ortholog pairs determination, followed
by Gene Ontology (GO) enrichment analysis conducted with
GOrilla, Panther classification system, and DAVID, and Gene Set
Enrichment Analysis with GSEA v.2.2.3 (Figure 1C).
Differential Expression (DE) Analysis
DE expression was analyzed with the R package edgeR v. 3.16.5
for each species separately and differentially expressed genes were
defined as genes with a false discovery rate<20% and an absolute
fold change higher than 1.1 in mouse and macaque. This is to
privilege sensitivity over specificity and highlight broad trends
firstly (24). Therefore, 1,187 and 302 differentially expressed
genes between tibias and calvariae were found in macaque and
mouse, respectively (Figures 2A,B). By comparing gene symbols,
there were 64 genes differentially expressed in both macaque
and mouse with the same direction of change (Figure 2C). A
conventional DE analysis with edgeR was not applied to the
pair of rat samples as count dispersion could not be estimated.
Instead, log2([cpm calvaria]/[cpm tibia]) >2 was selected as a
threshold, which gave 946 DE genes in rat. By comparing gene
symbols, there were 32 genes across all three species sharing
same direction of gene expression (Figure 2D), with specifically
interested genes annotated in Figures 2A,B. The list of genes
with all quantitative data were ranked in a descending order
in Table 1, based on fold changes of gene expression between
calvariae and tibias.
Gene Ontology (GO) Enrichment Analysis
To identify enriched GO terms in this list of shared DE
genes, GO enrichment analysis using the web-based GOrilla
application was performed first based on the 64 DE genes
shared between macaque and mouse. DE genes in rat were then
taken into account for quantitative analysis. Results suggested
that a group of genes (HOXA7, HOXA11, HOXC4, HOXC8,
HOXC9, HOXC10, ZIC1) are enriched in pattern specification
process at the level of biological process (Figures 3A,B). These
enriched genes are mainly binding sequence-specific DNA as
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FIGURE 1 | Pipeline design to discover cross species transcriptome signature of osteocytes in tibia and calvaria using RNA-Seq. (A) A principal component analysis
(PCA) suggested that samples cluster according to species but not to tissue sites (data are based on ortholog triplets determined with OrthoDB). (B) Pairwise
comparisons in a heat-map suggested samples from the same species but different sites have much more similar expression profile than samples of the same sites
from a different species. (C) The pipeline to determine cross-species transcriptome signature: Raw RNA-seq data was aligned to relevant genomes using HISAT2.
Differential expression (DE) was analyzed with the R package edgeR v. 3.16.5. Three-way ortholog pairs were determined based on gene symbols and the same
direction of expression. Gene Ontology (GO) enrichment analysis was conducted with GOrilla, Panther classification system, and DAVID, in addition to Gene Set
Enrichment Analysis with GSEA. After raw RNA-Seq data was mapped to relevant genomes, DE expression was performed for each species separately.
their molecular function (Figure 3C) and located in nuclear part
of the cellular component (Figure 3D).
Gene function analysis with the PANTHER classification
system suggested these DE genes mainly function in
the biological processes of organismal development and
morphogenesis (Table 2), not surprisingly in skeletal system
development and morphogenesis (Figures 4A,B). This result is
also consistent with the GSEA analysis which suggests in the tibia
that there are multiple gene sets involved in skeletal development
and morphogenesis. PANTHER protein class analysis confirms
the results by GOrilla analysis that many of these genes belong
to the family of homeobox transcription factor and are DNA
binding proteins.
Using the DAVID bioinformatics resources, functional
gene annotations suggest that many of these DE genes are
disease implicated genes. Bone mineral density ranks the
top of the disease list and includes 10 shared DE genes
(FOSB, BMP7, DKK1, FGF1, FRZB, HOXA11, HOXA7,
MEPE, SOST, and TNFSF10) (Figure 4C), many of which
associate with the Wnt signaling pathway. Among these DE
genes, all but FOSB were up-regulated in tibias in all three
species (Figure 4D).
DISCUSSION
The results of our experiments show a clearly defined set of
genes that are regulated differently in the calvaria and tibia
across mouse, rat, andmacaque. Given the different physiological
functions and responses to stimuli of bone cells at these two
sites, there is a compelling case that these 32 candidates account
for the bulk of this site specificity, although the mechanisms
by which they do this are not completely clear. The results
of the comparisons of the macaque paired samples are likely
to be closer to human physiology than rodents because both
are primates and therefore more related. However, the analysis
of differences across species allows us to identify candidates
that have a high likelihood of being broadly based regulators
of mammalian site-specific differences rather than those only
in any one of the separate species. Specifically, our analysis
shows that samples cluster according to species more than to
bone sample site (Figure 1A). We can interpret this to mean
that the impact of phylogenetic divergence on these samples is
stronger than any site-specific differences. This difference could
be due to fundamental regulatory differences in the skeleton of
different species, e.g., different functional units within compact
Frontiers in Endocrinology | www.frontiersin.org 4 September 2020 | Volume 11 | Article 581002
Wang et al. Cross Species, Site-Specific Osteocyte Transcriptomes
FIGURE 2 | Differential expression (DE) and orthologs analysis. After raw RNA-Seq data was mapped to relevant genomes, DE expression was performed for each
species separately. For macaque and mouse, genes with a false discovery rate <20% and an absolute fold change higher than 1.1 between samples from tibias and
calvariae were defined as having significantly differential expression. (A,B) The distribution of transcriptomes were shown in the volcano plots built based on Log2 FC
and FDR, with significant altered genes marked in red and specifically interested genes annotated. (C) There were 1,187 and 302 significantly DE genes in macaque
and mouse, respectively. There are 64 genes sharing the same direction of expression in both macaque and mouse. (D) For rat, log2([cpm calvaria]/[cpm tibia]) > 2
was regarded as significantly DE, which produced 946 DE genes in rat. By comparing gene symbols, there were 32 genes common to all three species that shared
same direction of gene expression.
bone. However, because of species differences, we believe the
genes we have identified are representative of site specific rather
than other differences. Using a single species for analysis could
therefore affect the power to detect important general site-
specific differences in expression, as any calvaria-tibia difference
would have to be larger than the gene expression divergence
between species. That inference is perhaps unsurprising, but
it has important implications on likely relevance of our data
when compared with studies performed in only one species
(10, 11).
The bioinformatic analysis of the data provided robust results
within and across species. Even where a conventional differential
expression (DE) analysis could not be applied to the pair of
rat samples (because count dispersion could not be estimated),
we were able to use a different method to assess significant
DE, identifying 946 DE rat genes. The segregation of our data
Frontiers in Endocrinology | www.frontiersin.org 5 September 2020 | Volume 11 | Article 581002
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TABLE 1 | Genes sharing same direction of expression across three species (fold changes: calvaria over tibia).
Mouse Macaque Rat
logFC logCPM PValue FDR logFC logCPM PValue FDR CalvariaCPM TibiaCPM logFC
HOXC9 −11.461493 4.0162301 8.01E-35 3.49E-31 −12.093574 5.0752142 7.15E-92 9.34E-88 0.1155338 27.7679897 −7.908963
IRX6 −2.279972 1.4212221 0.00174 0.1 −1.402094 2.4464369 0.00274 0.026 0.1155338 13.1126618 −6.826501
HOXC10 −10.738161 3.3064527 1.35E-26 2.93E-23 −10.803944 3.8065122 8.99E-47 1.96E-43 0.1155338 11.5699957 −6.645929
SEMA3E −4.317833 3.5107122 2.17E-09 0.000000979 −1.256249 3.673995 0.000165 0.00273 0.1155338 7.9704415 −6.108272
HOXB7 −7.320998 0.1523548 0.0000104 0.00158 −3.350367 2.6031017 0.000000242 0.00000997 0.1155338 6.6848864 −5.854516
HOXC8 −8.578174 3.5611009 1.84E-27 4.81E-24 −7.493305 4.434895 3.35E-60 8.76E-57 0.1155338 5.9135534 −5.677638
TPBG −2.449335 5.0845007 4.99E-13 3.83E-10 −1.781059 7.5889234 2.53E-13 3.93E-11 12.5931881 420.3765108 −5.060967
MAB21L2 −2.804119 1.6192526 0.000818 0.0595 −1.492797 4.7572048 1.11E-08 0.000000654 0.4621353 15.2981054 −5.048894
TBX18 −3.963703 2.9364331 8.65E-12 5.38E-09 −2.096215 0.7654256 0.0096 0.0676 0.693203 19.6689927 −4.826501
HOXC4 −5.411878 2.2721266 2.19E-10 0.000000124 −10.099025 3.1225023 1.19E-32 1.72E-29 0.3466015 8.356108 −4.591481
BMP7 −2.1987 4.5219894 9.17E-08 0.0000309 −2.434476 5.5399996 1.05E-13 1.77E-11 0.5776692 11.6985512 −4.339943
CNR1 −2.11486 1.6430663 0.000758 0.0563 −4.091067 0.6839788 0.0000267 0.000591 7.8563009 156.7091641 −4.318096
ISM1 −1.955616 5.9237582 9.81E-08 0.0000313 −1.340313 6.5592803 1.73E-11 1.92E-09 0.3466015 6.4277754 −4.21297
BNIP3 −2.108116 5.7664539 2.86E-08 0.0000116 −1.293536 6.6212956 0.0000138 0.000333 4.8524211 81.3756365 −4.06782
FGF1 −2.150014 5.0883888 4.88E-10 0.000000255 −1.229602 5.3376589 0.000000446 0.0000172 0.1155338 1.9283326 −4.060967
MEPE −1.718209 9.4859049 0.0000159 0.00225 −1.415031 13.2160688 0.00000899 0.000231 395.2412537 5455.767199 −3.786977
DKK1 −1.675265 7.2375087 0.0000542 0.00673 −1.164476 7.5887557 0.0000137 0.000331 0.8087369 9.3845521 −3.536546
HOXB5 −4.060927 −0.4653591 0.00303 0.144 −3.905861 0.5559288 0.00205 0.021 0.1155338 1.2855551 −3.476004
RGS5 −1.14423 7.098667 0.000229 0.0213 −1.689813 9.7182745 1.62E-11 1.81E-09 1.0398045 9.1274411 −3.133898
EPS8L2 −1.885136 2.9125401 0.0000969 0.0103 −2.152398 0.3353361 0.0063 0.0494 1.9640752 13.3697728 −2.767053
MAPT −1.752134 4.6115873 0.00112 0.0732 −1.352051 4.3814725 0.0000594 0.00117 13.0553235 86.5178568 −2.72836
SOST −2.816051 12.2756927 7.77E-08 0.0000282 −1.592744 14.2838757 2.27E-12 2.9E-10 0.3466015 1.9283326 −2.476004
DOK5 −1.482686 2.8671925 0.0033 0.153 −1.322071 2.0727781 0.00451 0.0386 7.3941655 38.6952079 −2.387696
TNFSF10 −1.247027 3.5784116 0.00218 0.116 −1.149214 5.9821759 5.53E-08 0.00000268 0.8087369 3.9852207 −2.300917
VLDLR −1.540378 6.2706147 0.00325 0.152 −1.199284 3.2402898 0.00158 0.0172 5.661158 27.7679897 −2.294254
SPARCL1 −1.409078 5.4723974 0.0000207 0.0029 −1.148213 6.921351 0.0000776 0.00146 109.1794752 517.4359193 −2.244679
HOXC5 −7.603457 0.3874172 0.00000282 0.000518 −6.992112 0.3315997 0.00000136 0.0000455 0.3466015 1.5426661 −2.154076
STC2 −1.726491 4.0178768 0.0000843 0.00922 −1.364338 2.3536737 0.00431 0.0372 2.5417444 11.1843292 −2.137588
NRN1 −3.169334 4.2319677 0.000000107 0.0000331 −1.856955 5.2077827 1.52E-08 0.000000857 1.9640752 8.613219 −2.132702
FRZB −4.718328 5.175902 4.95E-22 6.47E-19 −1.280146 7.8660153 0.000431 0.00603 0.693203 2.9567767 −2.092675
FOSB 2.561736 2.5506365 0.00000287 0.00052 5.180265 6.7767497 1.01E-11 1.18E-09 13.7485265 1.9283326 2.833851
ZIC1 7.040348 2.6521869 9.23E-08 0.0000309 7.91982 1.0259272 1.09E-09 8.36E-08 1.1553384 0.1285555 3.167852
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FIGURE 3 | Gene Ontology (GO) enrichment analysis. GOrilla application was firstly performed on the 64 DE genes shared between macaque and mouse. DE genes
in rat were then taken into account when quantitative analysis was performed. (A) At the level of biological process, a group of genes (HOXA7, HOXA11, HOXC4,
HOXC8, HOXC9, HOXC10, ZIC1) were enriched in pattern specification process. (B) These genes were significantly up-regulated in tibias in all three species, apart
from ZIC1. (C) These enriched DE genes mainly bind sequence-specific DNA as their molecular function and (D) located in nuclear part of the cellular component.
P-value color scale for (A,C,D).
into patterning genes (HOXA7, HOXA11, HOXC4, HOXC8,
HOXC9, HOXC10, ZIC1) and 8 others known to be related to the
regulation of bone mass and architecture (FOSB, BMP7, DKK1,
FGF1, FRZB, MEPE, SOST, and TNFSF10).
We show that some of these genes (i.e., HOXC8, HOXC9,
HOXC10) are almost exclusively expressed in tibias, at levels
>64-fold higher than in calvariae. This is consistent with other
studies that suggested HOX genes are pivotal in patterning
the axial and appendicular skeleton, particularly for embryonic
long bone development (33–39). This is consistent with their
participation in cartilage differentiation in the process of
endochondral ossification which is the way that long bones grow,
but is not involved in the intramembranous ossification that
leads to the formation of the flat bones of the skull (39–45).
The involvement of a large group of HOX transcription factors
indicates that the site-specific difference in regulating response
to mechanical loading by osteocytes is partly a genetically
determined baseline structure since embryonic stage.
Using the DAVID bioinformatics resources to identify DE
genes involved in diseases, we found bone mineral density
diseases ranking the top of the list and include implicated genes:
BMP7, DKK1, FGF1, FRZB, MEPE, SOST, FOSB, and TNFSF10
(or TRAIL). Most of these genes code for secreted proteins and
are up-regulated in osteocytes from tibias except FOSB. This
list includes not only anabolic factors that would be expected
to increase bone density (BMP7, FGF1, FRZB, and FOSB) but
also catabolic factors (DKK1, SOST, MEPE, TNFSF10) with
roles in bone remodeling, skeletogenesis and patterning (46–
52). More interestingly, many of these genes, including FRZB
(53, 54), BMP (55), FGF (56), DKK1 (57, 58), SOST (59),
and MEPE (60–62), have long been shown to regulate skeletal
development in association or crosstalk with the canonical Wnt
signaling (55, 63). The identification of these bone mineral
density and Wnt signaling-related, soluble proteins suggests
osteocytes at different sites response to mechanical loading
differently via potential paracrine and/or endocrine agents.
Upon response to strain, osteocytes regulate bone remodeling
with precisely tuned balance between anabolic and catabolic
effects, targeting both osteoblasts and osteoclasts. Intriguingly,
Sost−/− mice were shown to have resistance to mechanical
unloading-induced bone loss and exhibited high bone mass (64),
which underscores our results that Sost is less expressed in the
skull (with its insensitivity to disuse) but is more expressed
in the tibia which requires significant mechanical loading to
maintain mass. Moreover, this is also reflected by pathological
conditions caused by disrupting transcription of the SOST gene
and subsequently Wnt signaling, such as sclerosteosis and the
van Buchem syndrome (VBCH). Both these two closely related
diseases feature generalized sclerosis, including the enlargement
of the skull which endures lower physical mechanical strains
(65–67). All these indicate that the canonical Wnt signaling
pathway dictates skeletal site differences through regulating
bone’s adaptive response to mechanical loading (16, 68). This
could be achieved by osteocytes through a Sost-dependent
feedback mechanism of maintaining quiescent bone-lining cells
which are the main source of osteoblasts in adulthood (69, 70).
However, other possible pathways could not be overlooked, for
example, zinc finger protein of cerebellum (Zic) family member
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TABLE 2 | Gene function in biological process analysis with the PANTHER classification.
Term Genes
Regulation of animal organ
formation
FGF1, DKK1, BMP7, HOXA11
Regulation of multicellular
organismal development
HOXA7, MAPT, CNR1, FRZB, TBX18, SOST, FGF1, MEIS2, DKK1, HOXB7, BMP7, SEMA3E, VLDLR, GAL, MEPE, EAF2, HOXA11, TPBG
Regulation of multicellular
organismal process
HOXA7, STC2, MAPT, CNR1, STC1, FRZB, TBX18, SOST, FGF1, MEIS2, DKK1, HOXB7, CLU, BMP7, SEMA3E, VLDLR, GAL, MFAP4,
MEPE, EAF2, HOXA11, MYL4, TPBG
Embryonic skeletal system
morphogenesis
HOXA7, TBX15, HOXC9, HOXB7, BMP7, HOXB5, HOXA11
Skeletal system
morphogenesis
HOXA7, TBX15, STC1, HOXC9, HOXB7, BMP7, HOXB5, HOXC8, HOXA11
Animal organ
morphogenesis
HOXA7, TBX15, STC1, FRZB, HOXC9, FGF1, HOXB7, BMP7, HOXB5, ZIC1, HOXC4, HOXC8, HOXA11
Single-organism
developmental process
HOXA7, STC2, MAPT, TBX15, CNR1, STC1, FRZB, HOXC9, NRN1, HOXC10, TBX18, FGF1, MEIS2, DKK1, HOXB7, CLU, BMP7,
CRABP1, MECOM, TNFSF10, SEMA3E, DOK5, VLDLR, HOXB5, GAL, AK4, CECR2, ZIC1, HOXC4, BNIP3, HOXC5, MEPE, MAB21L2,
MATN3, HAPLN1, HOXC8, HOXA11, PITX1, ZIC2
Developmental process HOXA7, STC2, MAPT, TBX15, CNR1, STC1, FRZB, HOXC9, NRN1, HOXC10, TBX18, FGF1, MEIS2, DKK1, HOXB7, CLU, BMP7,
CRABP1, MECOM, TNFSF10, SEMA3E, DOK5, VLDLR, HOXB5, GAL, AK4, CECR2, ZIC1, HOXC4, BNIP3, SPARCL1, HOXC5, MEPE,
MAB21L2, MATN3, HAPLN1, HOXC8, HOXA11, PITX1, ZIC2
Animal organ development HOXA7, STC2, TBX15, STC1, FRZB, HOXC9, HOXC10, FGF1, MEIS2, DKK1, HOXB7, BMP7, MECOM, TNFSF10, VLDLR, HOXB5,
AK4, CECR2, ZIC1, HOXC4, BNIP3, MEPE, MAB21L2, HOXC8, HOXA11, PITX1, ZIC2
Anatomical structure
development
HOXA7, STC2, MAPT, TBX15, CNR1, STC1, FRZB, HOXC9, NRN1, HOXC10, TBX18, FGF1, MEIS2, DKK1, HOXB7, CLU, BMP7,
CRABP1, MECOM, TNFSF10, SEMA3E, DOK5, VLDLR, HOXB5, GAL, AK4, CECR2, ZIC1, HOXC4, BNIP3, SPARCL1, HOXC5, MEPE,
MAB21L2, MATN3, HAPLN1, HOXC8, HOXA11, PITX1, ZIC2
System development HOXA7, STC2, MAPT, TBX15, CNR1, STC1, FRZB, HOXC9, NRN1, HOXC10, TBX18, FGF1, MEIS2, DKK1, HOXB7, CLU, BMP7,
MECOM, TNFSF10, SEMA3E, DOK5, VLDLR, HOXB5, GAL, AK4, CECR2, ZIC1, HOXC4, BNIP3, HOXC5, MEPE, MAB21L2, MATN3,
HAPLN1, HOXC8, HOXA11, PITX1, ZIC2
Multicellular organism
development
HOXA7, STC2, MAPT, TBX15, CNR1, STC1, FRZB, HOXC9, NRN1, HOXC10, TBX18, FGF1, MEIS2, DKK1, HOXB7, CLU, BMP7,
CRABP1, MECOM, TNFSF10, SEMA3E, DOK5, VLDLR, HOXB5, GAL, AK4, CECR2, ZIC1, HOXC4, BNIP3, HOXC5, MEPE, MAB21L2,
MATN3, HAPLN1, HOXC8, HOXA11, PITX1, ZIC2
Single-multicellular
organism process
HOXA7, STC2, MAPT, TBX15, CNR1, STC1, FRZB, HOXC9, NRN1, HOXC10, TBX18, SOST, FGF1, MEIS2, DKK1, HOXB7, CLU, BMP7,
CRABP1, MECOM, TNFSF10, SEMA3E, DOK5, VLDLR, HOXB5, GAL, AK4, CECR2, ZIC1, HOXC4, BNIP3, HOXC5, MEPE, MAB21L2,
MATN3, HAPLN1, HOXC8, HOXA11, PITX1, ZIC2
Multicellular organismal
process
HOXA7, STC2, MAPT, TBX15, CNR1, STC1, FRZB, HOXC9, NRN1, HOXC10, TBX18, SOST, FGF1, MEIS2, DKK1, HOXB7, CLU, BMP7,
CRABP1, MECOM, TNFSF10, SEMA3E, DOK5, VLDLR, HOXB5, GAL, AK4, CECR2, ZIC1, HOXC4, BNIP3, HOXC5, MEPE, MAB21L2,
MATN3, FOSB, HAPLN1, HOXC8, HOXA11, PITX1, MYL4, ZIC2
Anatomical structure
morphogenesis
HOXA7, TBX15, STC1, FRZB, HOXC9, NRN1, HOXC10, FGF1, DKK1, HOXB7, CLU, BMP7, SEMA3E, DOK5, VLDLR, HOXB5, CECR2,
ZIC1, HOXC4, MAB21L2, HOXC8, HOXA11, PITX1
Skeletal system
development
HOXA7, TBX15, STC1, FRZB, HOXC9, HOXC10, HOXB7, BMP7, HOXB5, HOXC4, HOXC5, MEPE, MATN3, HAPLN1, HOXC8, HOXA11,
PITX1
Embryonic skeletal system
development
HOXA7, TBX15, HOXC9, HOXB7, BMP7, HOXB5, HOXC5, HOXA11
Embryo development HOXA7, TBX15, FRZB, HOXC9, HOXC10, DKK1, HOXB7, BMP7, HOXB5, CECR2, ZIC1, HOXC4, HOXC5, MAB21L2, HOXA11, PITX1
Embryonic organ
morphogenesis
HOXA7, TBX15, FRZB, HOXC9, HOXB7, BMP7, HOXB5, ZIC1, HOXC4, HOXA11
Embryonic morphogenesis HOXA7, TBX15, FRZB, HOXC9, HOXC10, DKK1, HOXB7, BMP7, HOXB5, CECR2, ZIC1, HOXC4, MAB21L2, HOXA11, PITX1
Embryonic organ
development
HOXA7, TBX15, FRZB, HOXC9, HOXB7, BMP7, HOXB5, ZIC1, HOXC4, HOXA11
Anterior/posterior pattern
specification
HOXA7, HOXC9, HOXC10, DKK1, HOXB7, HOXB5, HOXC4, HOXC5, HOXC8, HOXA11
Regionalization HOXA7, HOXC9, HOXC10, DKK1, HOXB7, HOXB5, HOXC4, HOXC5, HOXC8, HOXA11
Pattern specification
process
HOXA7, STC1, HOXC9, HOXC10, DKK1, HOXB7, BMP7, HOXB5, ZIC1, HOXC4, HOXC5, HOXC8, HOXA11
Negative regulation of
developmental process
HOXA7, STC2, MAPT, FRZB, TBX18, SOST, MEIS2, DKK1, BMP7, SEMA3E, GAL, BNIP3, MEPE, EAF2
Positive regulation of
transcription,
DNA-templated
HOXA7, HOXC10, SOST, FGF1, MEIS2, HOXB7, BMP7, MECOM, HOXB5, GAL, ZIC1, EAF2, FOSB, HOXA11, PITX1, ZIC2
(Continued)
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TABLE 2 | Continued
Term Genes
Positive regulation of nucleic
acid-templated transcription
HOXA7, HOXC10, SOST, FGF1, MEIS2, HOXB7, BMP7, MECOM, HOXB5, GAL, ZIC1, EAF2, FOSB, HOXA11, PITX1, ZIC2
Positive regulation of RNA
biosynthetic process
HOXA7, HOXC10, SOST, FGF1, MEIS2, HOXB7, BMP7, MECOM, HOXB5, GAL, ZIC1, EAF2, FOSB, HOXA11, PITX1, ZIC2
Regulation of transcription
from RNA polymerase II
promoter
HOXA7, TBX15, HOXC10, TBX18, SOST, FGF1, MEIS2, DKK1, HOXB7, BMP7, VLDLR, HOXB5, GAL, ZIC1, HOXC5, EAF2, FOSB,
HOXC8, PITX1
FIGURE 4 | Gene function analysis. Gene function analysis with the PANTHER classification system and DAVID. PANTHER analysis suggested a list of DE genes that
were up-regulated in osteocytes from tibias across species in biological processes of skeletal system development (A) and morphogenesis (B). (C) Functional gene
annotations using DAVID suggested that 10 cross-species DE genes (FOSB, BMP7, DKK1, FGF1, FRZB, HOXA11, HOXA7, MEPE, SOST, and TNFSF10) were
implicated genes in bone mineral density related diseases, which ranks the top of the list. (D) Among these DE genes, only FOSB was down-regulated in tibias in all
three species.
transcription factor Zic1, one of only two down-regulated gene in
tibias in our study. Although not annotated by DAVID as a bone
mineral density disease implicated gene, ZIC1 has been suggested
a site-specific expression pattern by osteocytes and to act as a
link between mechanosensing andWnt signaling (71). The lower
expression of ZIC1 in tibias suggests a potential negative feedback
pathway in osteocyte in response to mechanical stimuli.
We recognize that the lack of additional technical validation
and low number of biological replicates impacts on the strength
of the conclusions that can be drawn from the study and
the potential targets we have identified need to be confirmed
and explored using in vitro models and transgenic mice in
future. We can conclude that a relatively small number of
genes are differentially expressed between two skeletal sites in
multiple species: results that are consistent with some but not
all differences found by others exploring site-specific differences
in the skeleton and our data cast new light onto possible
mechanisms for those differences as well as potential future
clinical benefits. The approach we have used appears to have
advantages over microarray studies in a single species, allowing
greater refinement of data to identify key regulators of the site-
specific characteristics of the skeleton. This has been underscored
by a very recent study using scRNA-Seq, suggesting that
osteoblasts isolated from calvaria and cortical long bone in mice
have similar transcriptomes (12), although the authors suggest
that changes after isolation of the cells may have contributed
to the lack of differences identified. To impact upon bone
pathology, therapies to make long bones behave more like the
flat bones of the skull in respect of their susceptibility to loss in
response to aging, disuse, and hormonal or nutritional changes
could provide powerful methods to maintain bone strength
throughout life and provide a strong biological explanation
for the promising development of sclerostin antibodies for the
treatment of osteoporosis (72, 73).
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